CBD Helps 84% of Child Participants with Severe Epilepsy, Survey Indicates

A survey conducted by the Department of Neurology at Stanford University indicated that 84% of child participants with severe epilepsy had their seizures significantly reduced with CBD-enriched cannabis.

The survey, published in 2013, asked the parents of nineteen children (age 2-16) suffering from treatment-resistant epilepsy’s to record their child’s progress while using cannabis oil high in cannabidiol (CBD), a non-psychotropic cannabinoid.

Thirteen of the child participants had Dravet Syndrome, four had Doose Sydrome and two had Lennox-Gastaut Sydrome. These are three of the most severe forms of epilepsy and can be fatal, especially amongst young children.

Before the survey was conducted, the participants were asked how many anti-epileptic drugs their child had been prescribed; the average answer was twelve.

The results indicated that Sixteen (84%) of the 19 parents reported a reduction in their child’s seizure frequency while taking cannabidiol-enriched cannabis. Of these, two (11%) reported complete seizure freedom, eight (42%) reported a greater than 80% reduction in seizure frequency, and six (32%) reported a 25-60% seizure reduction. Other beneficial effects included increased alertness, better mood and improved sleep. Side effects included drowsiness and fatigue.

Despite the positive results, the Department of Neurology at Stanford argued that “objective measurements of a standardized preparation of pure cannabidiol are needed to determine whether it is safe, well tolerated and efficacious at controlling seizures in this difficult-to-treat pediatric population.”

Two other points of contention are the duration of CBD-rich cannabis ingestion, which ranged from two weeks to fifty weeks. This meant that no conclusion could be drawn as to whether duration of administration had any affect on participants.

Also, all participants of the study were selected from a “Facebook group dedicated to sharing information about the use of cannabidiol-enriched cannabis”. This should be considered when analysing the results, as the participants had prior knowledge and opinions on the subject matter, potentially leading to biased results.

You can read the full report on our Research Library here.

With an international team of writers and over a decade of experience in the industry, MedicalMarijuana.co.uk aim to bring you the very latest in Medical Cannabis news from across the globe.



  1. Jerry Johnson says:

    Does it get you high

  2. MedicalMarijuana AdminMedicalMarijuana Admin says:

    No CBD is a non-psychoactive cannabinoid.

  3. Nathan Couch says:

    My epilepsy has been going for four years. I’ve tried 16 medications with no luck. It saddens me that as an adult with medicine resistant epilepsy that there are no more trials for adults. If there’s any information regarding trials for adults in California with medicine resistant epilepsy I currently suffer from around 30 Grand Mall seizures a month. Any help or advice would be greatly appreciated thank you very much for your time and I hope you have a blessed day.

    1. TomTom says:


      Have you tried any CBD products before? Either derived from hemp, which are normally legal or from drug variety strains (with THC) which are often illegal?

Have Your Say


Related News